197 related articles for article (PubMed ID: 36036380)
1. Colorectal Cancer Cell Differentiation Trajectory Predicts Patient Immunotherapy Response and Prognosis.
Qin Y; Li M; Lin Q; Pan X; Liang Y; Huang Z; Liu Z; Huang L; Fang M
Cancer Control; 2022; 29():10732748221121382. PubMed ID: 36036380
[TBL] [Abstract][Full Text] [Related]
2. Cell differentiation trajectory predicts patient potential immunotherapy response and prognosis in gastric cancer.
Xiang R; Rong Y; Ge Y; Song W; Ren J; Fu T
Aging (Albany NY); 2021 Feb; 13(4):5928-5945. PubMed ID: 33612483
[TBL] [Abstract][Full Text] [Related]
3. Pan-cancer analysis identifies migrasome-related genes as a potential immunotherapeutic target: A bulk omics research and single cell sequencing validation.
Qin Y; Yang J; Liang C; Liu J; Deng Z; Yan B; Fu Y; Luo Y; Li X; Wei X; Li W
Front Immunol; 2022; 13():994828. PubMed ID: 36405728
[TBL] [Abstract][Full Text] [Related]
4. Cell Differentiation Trajectory Predicts Prognosis and Immunotherapeutic Response in Clear Cell Renal Cell Carcinoma.
Xu J; Chen X; Chen Y; Wang Q; Jin Y; Zhao H
Genet Res (Camb); 2022; 2022():8422339. PubMed ID: 36530957
[TBL] [Abstract][Full Text] [Related]
5. Machine learning-based glycolysis-associated molecular classification reveals differences in prognosis, TME, and immunotherapy for colorectal cancer patients.
Wang Z; Shao Y; Zhang H; Lu Y; Chen Y; Shen H; Huang C; Wu J; Fu Z
Front Immunol; 2023; 14():1181985. PubMed ID: 37228620
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a TNF Family-Based Signature for Predicting Prognosis, Tumor Immune Characteristics, and Immunotherapy Response in Colorectal Cancer Patients.
Xiao Z; Nie K; Han T; Cheng L; Zhang Z; Peng W; Shi D
J Immunol Res; 2021; 2021():6439975. PubMed ID: 34541005
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of a Cancer-Immunity Cycle-Based Signature for Predicting Prognosis and Immunotherapy Response in Patients With Colorectal Cancer.
Hou Y; Zhang R; Zong J; Wang W; Zhou M; Yan Z; Li T; Gan W; Lv S; Zeng Z; Yang M
Front Immunol; 2022; 13():892512. PubMed ID: 35711437
[TBL] [Abstract][Full Text] [Related]
8. Cross-Talk Between m
Song W; Ren J; Xiang R; Yuan W; Fu T
Front Immunol; 2022; 13():740960. PubMed ID: 35350786
[TBL] [Abstract][Full Text] [Related]
9. Cell Differentiation Trajectory-Associated Molecular Classification of Osteosarcoma.
Xu A; Qian C; Lin J; Yu W; Jin J; Liu B; Tao H
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828292
[TBL] [Abstract][Full Text] [Related]
10. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
11. Prognostic-related genes for pancreatic cancer typing and immunotherapy response prediction based on single-cell sequencing data and bulk sequencing data.
Wang X; Jiang S; Zhou X; Wang X; Li L; Tang J
Oncol Res; 2023; 31(5):697-714. PubMed ID: 37547756
[TBL] [Abstract][Full Text] [Related]
12. Molecular Subtypes Based on Cell Differentiation Trajectories in Head and Neck Squamous Cell Carcinoma: Differential Prognosis and Immunotherapeutic Responses.
Huang ZD; Liu ZZ; Liu YY; Fu YC; Lin LL; Hu C; Gu HY; Wei RX
Front Immunol; 2021; 12():791621. PubMed ID: 35003112
[TBL] [Abstract][Full Text] [Related]
13. Single cell RNA sequencing reveals differentiation related genes with drawing implications in predicting prognosis and immunotherapy response in gliomas.
Zhou Z; Wei J; Yang Z; Bao Y; Jiang W; Lu B; Wang W; Li L
Sci Rep; 2022 Feb; 12(1):1872. PubMed ID: 35115572
[TBL] [Abstract][Full Text] [Related]
14. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
[TBL] [Abstract][Full Text] [Related]
15. The Effects of Differentially-Expressed Homeobox Family Genes on the Prognosis and HOXC6 on Immune Microenvironment Orchestration in Colorectal Cancer.
Qi L; Ye C; Zhang D; Bai R; Zheng S; Hu W; Yuan Y
Front Immunol; 2021; 12():781221. PubMed ID: 34950145
[TBL] [Abstract][Full Text] [Related]
16. An immune landscape based prognostic signature predicts the immune status and immunotherapeutic responses of patients with colorectal cancer.
Li M; Li W; Yang X; Wang H; Peng Y; Yin J; Lu Y; Liu L; Shang J; Zhao Q
Life Sci; 2020 Nov; 261():118368. PubMed ID: 32888940
[TBL] [Abstract][Full Text] [Related]
17. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
[TBL] [Abstract][Full Text] [Related]
18. Screening and identification of immune-related genes for immunotherapy and prognostic assessment in colorectal cancer patients.
Wang S; Cheng L; Jing F; Li G
BMC Med Genomics; 2022 Aug; 15(1):177. PubMed ID: 35941638
[TBL] [Abstract][Full Text] [Related]
19. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
[TBL] [Abstract][Full Text] [Related]
20. Bulk and single-cell transcriptome profiling reveal necroptosis-based molecular classification, tumor microenvironment infiltration characterization, and prognosis prediction in colorectal cancer.
Luo W; Xiang W; Gan L; Che J; Li J; Wang Y; Han L; Gu R; Ye L; Wang R; Zhang X; Xu Y; Dai W; Mo S; Li Q; Cai G
J Transl Med; 2022 May; 20(1):235. PubMed ID: 35590418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
